Subtype
Male Reproductive System Neoplasm
CI-CAN-00001107Explore in graph →
Non-malignant1,533 active trials27 approved drugs58 evidence items
- NCIt
- C3054
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001107Explore in graph →
Clinical trials
6,899 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01964170 | A Study to Compare the Effect of ASP3550 With Goserelin in Patients With Prostate Cancer | completed | Phase 3 | 234 | Astellas Pharma IncINDUSTRY | 1 | Oct 31, 2024 | clinicaltrials |
| NCT03686683 | Open- Label Trial of Sipuleucel-T Administered to Active Surveillance Patients for Newly Diagnosed Prostate Cancer(ProVent) | completed | Phase 3 | 532 | DendreonINDUSTRY | 1 | Oct 8, 2024 | clinicaltrials |
| NCT00365105 | Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer | completed | Phase 3 | 261 | Radiation Therapy Oncology GroupNETWORK | 1 | Sep 20, 2024 | clinicaltrials |
| NCT06601205 | Finasteride and Flutamide in Pre-surgical Trial in Prostate Cancer.(2F) | completed | Phase 2 / Phase 3 | 125 | Ente Ospedaliero Ospedali GallieraOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT01272050 | Radiation Therapy in Treating Patients With Relapsed Prostate Cancer After Surgery | completed | Phase 3 | 350 | Swiss Cancer InstituteOTHER | 3 | Aug 28, 2024 | clinicaltrials |
| NCT03389451 | 68Ga PSMA PET for Patients With Biochemical Recurrence of Prostate Cancer | completed | Phase 2 / Phase 3 | 30 | Michael Graham PhD, MDOTHER | 1 | Jul 12, 2024 | clinicaltrials |
| NCT04676334 | CATCH-R: A Rollover Study to Provide Continued Access to Rucaparib(CATCH-R) | completed | Phase 3 | 34 | pharmaand GmbHINDUSTRY | 6 | May 7, 2024 | clinicaltrials |
| NCT03388346 | 68Ga PSMA in Preprostatectomy Patients | completed | Phase 2 / Phase 3 | 22 | Michael Graham PhD, MDOTHER | 1 | Feb 15, 2024 | clinicaltrials |
| NCT04644822 | Safety and Efficacy of [18F]PSMA-1007 Injection in Suspected Persistent or Recurrent Prostate Cancer. | completed | Phase 3 | 100 | Centre for Probe Development and CommercializationOTHER | 1 | Feb 7, 2024 | clinicaltrials |
| NCT04887506 | TAVT-45 (Abiraterone Acetate) Granules in Patients With Prostate Cancer | completed | Phase 3 | 107 | Tavanta TherapeuticsINDUSTRY | 8 | Jan 16, 2024 | clinicaltrials |
| NCT01394263 | Study of Histrelin Subdermal Implant in Patients With Prostate Cancer | completed | Phase 3 | 59 | Endo USA Inc., a Keenova Therapeutics CompanyINDUSTRY | 0 | Jan 2, 2024 | clinicaltrials |
| NCT01697384 | Study to Evaluate Efficacy and Safety of Histrelin Subdermal Implant in Men With Advanced Prostate Cancer | completed | Phase 3 | 138 | Endo USA Inc., a Keenova Therapeutics CompanyINDUSTRY | 0 | Jan 2, 2024 | clinicaltrials |
| NCT03001869 | 68Ga-PSMA PET/CT in Prostate Cancer | completed | Phase 3 | 540 | Sir Mortimer B. Davis - Jewish General HospitalOTHER | 1 | Nov 27, 2023 | clinicaltrials |
| NCT00584532 | Effects of a Genistein Concentrated Polysaccharide (GCP) for Prostate Cancer on Active Surveillance.(GCP) | completed | Phase 2 / Phase 3 | 66 | University of California, DavisOTHER | 0 | Nov 24, 2023 | clinicaltrials |
| NCT00541047 | RADICALS - Radiotherapy and Androgen Deprivation In Combination After Local Surgery | completed | Phase 3 | 4,236 | University College, LondonOTHER | 2 | Nov 13, 2023 | clinicaltrials |
| NCT05197257 | 68Ga-PSMA-11 PET in Patients With Prostate Cancer | completed | Phase 3 | 39 | University of Colorado, DenverOTHER | 1 | Nov 13, 2023 | clinicaltrials |
| NCT02987543 | Study of Olaparib (Lynparza™) Versus Enzalutamide or Abiraterone Acetate in Men With Metastatic Castration-Resistant Prostate Cancer (PROfound Study) | completed | Phase 3 | 387 | AstraZenecaINDUSTRY | 20 | Oct 6, 2023 | clinicaltrials |
| NCT01666808 | FACBC Outcomes for Post Prostatectomy | completed | Phase 2 / Phase 3 | 165 | Emory UniversityOTHER | 1 | Aug 2, 2023 | clinicaltrials |
| NCT04914195 | Leuprolide Acetate 3.75 mg Depot Injection for Patients With Advanced Prostate Cancer | completed | Phase 3 | 155 | Bharat Serums and Vaccines LimitedINDUSTRY | 1 | Aug 1, 2023 | clinicaltrials |
| NCT00664456 | Luteinizing Hormone-Releasing Hormone Agonist Therapy and Iodine I 125 Implant in Treating Patients With Previously Untreated Prostate Cancer(SHIP0804) | completed | Phase 3 | 421 | Translational Research Center for Medical Innovation, Kobe, Hyogo, JapanOTHER | 1 | Jul 24, 2023 | clinicaltrials |
| NCT02015871 | An Extension Long-term Safety and Tolerability Trial of Degarelix in Chinese Patients With Prostate Cancer(PandaExtension) | completed | Phase 3 | 206 | Ferring PharmaceuticalsINDUSTRY | 1 | Jun 18, 2023 | clinicaltrials |
| NCT00027859 | Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancer | completed | Phase 3 | — | Eastern Cooperative Oncology GroupNETWORK | 1 | Jun 15, 2023 | clinicaltrials |
| NCT00060398 | Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer | completed | Phase 3 | 282 | Eastern Cooperative Oncology GroupNETWORK | 1 | Jun 15, 2023 | clinicaltrials |
| NCT02659527 | PET/MRI in Patients With Suspected Prostate Cancer | completed | Phase 3 | 220 | Medical University of ViennaOTHER | 1 | Jun 15, 2023 | clinicaltrials |
| NCT00106691 | Prostate Cancer Prevention Study for Men With High Grade PIN (Prostatic Intraepithelial Neoplasia) | completed | Phase 3 | 1,589 | GTxINDUSTRY | 3 | Jun 12, 2023 | clinicaltrials |
| NCT02624518 | 68Ga-RM2 PET/MRI in Biochemically Recurrent Prostate Cancer | completed | Phase 2 / Phase 3 | 122 | Andrei IagaruOTHER | 1 | Apr 10, 2023 | clinicaltrials |
| NCT03103152 | A Study to Examine the Effectiveness of Aspirin and/or Vitamin D3 to Prevent Prostate Cancer Progression(PROVENT) | completed | Phase 2 / Phase 3 | 104 | Queen Mary University of LondonOTHER | 1 | Mar 29, 2023 | clinicaltrials |
| NCT01238172 | Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance | completed | Phase 3 | 478 | Alliance for Clinical Trials in OncologyOTHER | 1 | Mar 21, 2023 | clinicaltrials |
| NCT04627896 | Targeted Microwave Focal Therapy | completed | Phase 2 / Phase 3 | 11 | A.O.U. Città della Salute e della ScienzaOTHER | 1 | Feb 2, 2023 | clinicaltrials |
| NCT04854993 | Recovery From dNMB Using Different Sugammadex Doses in Elderly Patients Undergoing Robot-assisted Prostatectomy(RECIR) | completed | Phase 3 | 34 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Jan 25, 2023 | clinicaltrials |
| NCT00033631 | Radiation Therapy in Treating Patients With Stage II Prostate Cancer | completed | Phase 3 | 1,534 | Radiation Therapy Oncology GroupNETWORK | 2 | Jan 18, 2023 | clinicaltrials |
| NCT00055731 | Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse | completed | Phase 3 | 413 | UNICANCEROTHER | 1 | Jan 18, 2023 | clinicaltrials |
| NCT00331773 | Radiation Therapy in Treating Patients With Stage II Prostate Cancer | completed | Phase 3 | 1,116 | Radiation Therapy Oncology GroupNETWORK | 2 | Jan 18, 2023 | clinicaltrials |
| NCT00004124 | S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer | completed | Phase 3 | 983 | SWOG Cancer Research NetworkNETWORK | 1 | Dec 30, 2022 | clinicaltrials |
| NCT00377156 | Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases | completed | Phase 3 | 213 | Alliance for Clinical Trials in OncologyOTHER | 2 | Sep 16, 2022 | clinicaltrials |
| NCT00288080 | Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer | completed | Phase 3 | 612 | Radiation Therapy Oncology GroupNETWORK | 2 | Jun 21, 2022 | clinicaltrials |
| NCT00002874 | Radiation Therapy With or Without Bicalutamide for Recurrent pT3N0 Prostate Cancer After Radical Prostatectomy | completed | Phase 3 | 840 | Radiation Therapy Oncology GroupNETWORK | 2 | Jun 15, 2022 | clinicaltrials |
| NCT00005044 | Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer | completed | Phase 3 | 1,579 | Radiation Therapy Oncology GroupNETWORK | 2 | Jun 15, 2022 | clinicaltrials |
| NCT01517802 | A Study That Provides Long-term Safety Follow-up and Examines Long-term Exposure to Abiraterone Acetate | completed | Phase 3 | 32 | Janssen Research & Development, LLCINDUSTRY | 7 | May 10, 2022 | clinicaltrials |
| NCT02678351 | 68Ga-PSMA-11 PET/MRI in Finding Tumors in Patients With Intermediate or High-Risk Prostate Cancer Undergoing Surgery | completed | Phase 2 / Phase 3 | 74 | Andrei IagaruOTHER | 1 | Mar 4, 2022 | clinicaltrials |
| NCT03085095 | A Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer(HERO) | completed | Phase 3 | 1,134 | Myovant Sciences GmbHINDUSTRY | 22 | Jan 18, 2022 | clinicaltrials |
| NCT02673151 | 68Ga-PSMA PET/CT in Detecting Prostate Cancer Recurrence in Patients With Elevated PSA After Initial Treatment | completed | Phase 2 / Phase 3 | 61 | Andrei IagaruOTHER | 1 | Jan 13, 2022 | clinicaltrials |
| NCT00116142 | Hormone Suppression and Radiation Therapy for 6 Months With/Without Docetaxel for High Risk Prostate Cancer | completed | Phase 3 | 350 | Dana-Farber Cancer InstituteOTHER | 1 | Jan 11, 2022 | clinicaltrials |
| NCT00116220 | Study of External Beam Radiation Therapy With and Without Hormonal Therapy to Treat Prostate Cancer | completed | Phase 3 | 206 | Dana-Farber Cancer InstituteOTHER | 1 | Jan 6, 2022 | clinicaltrials |
| NCT00134056 | S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy | completed | Phase 3 | 1,038 | SWOG Cancer Research NetworkNETWORK | 1 | Oct 27, 2021 | clinicaltrials |
| NCT03353740 | Gallium-68 PSMA-11 Positron Emission Tomography (PET) Imaging in Patients With Biochemical Recurrence | completed | Phase 3 | 346 | Thomas HopeOTHER | 1 | Oct 21, 2021 | clinicaltrials |
| NCT04563936 | Efficacy and Safety of LY01005 in Patients With Prostate Cancer Compared to ZOLADEX® | completed | Phase 3 | 290 | Luye Pharma Group Ltd.INDUSTRY | 1 | Aug 26, 2021 | clinicaltrials |
| NCT03803475 | Gallium-68 PSMA-11 PET Imaging in Prostate Cancer Patients | completed | Phase 3 | 485 | Thomas HopeOTHER | 1 | Aug 24, 2021 | clinicaltrials |
| NCT02981368 | Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer(OSPREY) | completed | Phase 2 / Phase 3 | 385 | Progenics Pharmaceuticals, Inc.INDUSTRY | 2 | Aug 9, 2021 | clinicaltrials |
Data updated 23 days agoSource updated Oct 31, 2024source: clinicaltrials